Pharmacometric Methods and Novel Models for Discrete Data

Pharmacodynamic processes and disease progression are increasingly characterized with pharmacometric models. However, modelling options for discrete-type responses remain limited, although these response variables are commonly encountered clinical endpoints. Types of data defined as discrete data ar...

Full description

Bibliographic Details
Main Author: Plan, Elodie L
Format: Doctoral Thesis
Language:English
Published: Uppsala universitet, Institutionen för farmaceutisk biovetenskap 2011
Subjects:
AGQ
Online Access:http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-150929
http://nbn-resolving.de/urn:isbn:978-91-554-8064-6
id ndltd-UPSALLA1-oai-DiVA.org-uu-150929
record_format oai_dc
spelling ndltd-UPSALLA1-oai-DiVA.org-uu-1509292013-01-08T13:07:29ZPharmacometric Methods and Novel Models for Discrete DataengPlan, Elodie LUppsala universitet, Institutionen för farmaceutisk biovetenskapUppsala : Acta Universitatis Upsaliensis2011Pharmacometricspharmacodynamicsdisease progressionmodellingdiscrete datacountordered categoricalrepeated time-to-eventRTTCERCEpTNONMEMFOCELAPLACESAEMAGQpain scoresepilepsy seizuresgastroesophageal symptomsstatistical powersimulationsdiagnosticsPHARMACYFARMACIPharmacodynamic processes and disease progression are increasingly characterized with pharmacometric models. However, modelling options for discrete-type responses remain limited, although these response variables are commonly encountered clinical endpoints. Types of data defined as discrete data are generally ordinal, e.g. symptom severity, count, i.e. event frequency, and time-to-event, i.e. event occurrence. Underlying assumptions accompanying discrete data models need investigation and possibly adaptations in order to expand their use. Moreover, because these models are highly non-linear, estimation with linearization-based maximum likelihood methods may be biased. The aim of this thesis was to explore pharmacometric methods and novel models for discrete data through (i) the investigation of benefits of treating discrete data with different modelling approaches, (ii) evaluations of the performance of several estimation methods for discrete models, and (iii) the development of novel models for the handling of complex discrete data recorded during (pre-)clinical studies. A simulation study indicated that approaches such as a truncated Poisson model and a logit-transformed continuous model were adequate for treating ordinal data ranked on a 0-10 scale. Features that handled serial correlation and underdispersion were developed for the models to subsequently fit real pain scores. The performance of nine estimation methods was studied for dose-response continuous models. Other types of serially correlated count models were studied for the analysis of overdispersed data represented by the number of epilepsy seizures per day. For these types of models, the commonly used Laplace estimation method presented a bias, whereas the adaptive Gaussian quadrature method did not. Count models were also compared to repeated time-to-event models when the exact time of gastroesophageal symptom occurrence was known. Two new model structures handling repeated time-to-categorical events, i.e. events with an ordinal severity aspect, were introduced. Laplace and two expectation-maximisation estimation methods were found to be performing well for frequent repeated time-to-event models. In conclusion, this thesis presents approaches, estimation methods, and diagnostics adapted for treating discrete data. Novel models and diagnostics were developed when lacking and applied to biological observations. Doctoral thesis, comprehensive summaryinfo:eu-repo/semantics/doctoralThesistexthttp://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-150929urn:isbn:978-91-554-8064-6Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy, 1651-6192 ; 145application/pdfinfo:eu-repo/semantics/openAccess
collection NDLTD
language English
format Doctoral Thesis
sources NDLTD
topic Pharmacometrics
pharmacodynamics
disease progression
modelling
discrete data
count
ordered categorical
repeated time-to-event
RTTCE
RCEpT
NONMEM
FOCE
LAPLACE
SAEM
AGQ
pain scores
epilepsy seizures
gastroesophageal symptoms
statistical power
simulations
diagnostics
PHARMACY
FARMACI
spellingShingle Pharmacometrics
pharmacodynamics
disease progression
modelling
discrete data
count
ordered categorical
repeated time-to-event
RTTCE
RCEpT
NONMEM
FOCE
LAPLACE
SAEM
AGQ
pain scores
epilepsy seizures
gastroesophageal symptoms
statistical power
simulations
diagnostics
PHARMACY
FARMACI
Plan, Elodie L
Pharmacometric Methods and Novel Models for Discrete Data
description Pharmacodynamic processes and disease progression are increasingly characterized with pharmacometric models. However, modelling options for discrete-type responses remain limited, although these response variables are commonly encountered clinical endpoints. Types of data defined as discrete data are generally ordinal, e.g. symptom severity, count, i.e. event frequency, and time-to-event, i.e. event occurrence. Underlying assumptions accompanying discrete data models need investigation and possibly adaptations in order to expand their use. Moreover, because these models are highly non-linear, estimation with linearization-based maximum likelihood methods may be biased. The aim of this thesis was to explore pharmacometric methods and novel models for discrete data through (i) the investigation of benefits of treating discrete data with different modelling approaches, (ii) evaluations of the performance of several estimation methods for discrete models, and (iii) the development of novel models for the handling of complex discrete data recorded during (pre-)clinical studies. A simulation study indicated that approaches such as a truncated Poisson model and a logit-transformed continuous model were adequate for treating ordinal data ranked on a 0-10 scale. Features that handled serial correlation and underdispersion were developed for the models to subsequently fit real pain scores. The performance of nine estimation methods was studied for dose-response continuous models. Other types of serially correlated count models were studied for the analysis of overdispersed data represented by the number of epilepsy seizures per day. For these types of models, the commonly used Laplace estimation method presented a bias, whereas the adaptive Gaussian quadrature method did not. Count models were also compared to repeated time-to-event models when the exact time of gastroesophageal symptom occurrence was known. Two new model structures handling repeated time-to-categorical events, i.e. events with an ordinal severity aspect, were introduced. Laplace and two expectation-maximisation estimation methods were found to be performing well for frequent repeated time-to-event models. In conclusion, this thesis presents approaches, estimation methods, and diagnostics adapted for treating discrete data. Novel models and diagnostics were developed when lacking and applied to biological observations.
author Plan, Elodie L
author_facet Plan, Elodie L
author_sort Plan, Elodie L
title Pharmacometric Methods and Novel Models for Discrete Data
title_short Pharmacometric Methods and Novel Models for Discrete Data
title_full Pharmacometric Methods and Novel Models for Discrete Data
title_fullStr Pharmacometric Methods and Novel Models for Discrete Data
title_full_unstemmed Pharmacometric Methods and Novel Models for Discrete Data
title_sort pharmacometric methods and novel models for discrete data
publisher Uppsala universitet, Institutionen för farmaceutisk biovetenskap
publishDate 2011
url http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-150929
http://nbn-resolving.de/urn:isbn:978-91-554-8064-6
work_keys_str_mv AT planelodiel pharmacometricmethodsandnovelmodelsfordiscretedata
_version_ 1716509760469073920